Latest Rosalind Advisors, Inc. Stock Portfolio
Rosalind Advisors, Inc. Performance:
2025 Q3: 23.11%YTD: 15.39%2024: 7.39%
Performance for 2025 Q3 is 23.11%, and YTD is 15.39%, and 2024 is 7.39%.
About Rosalind Advisors, Inc. and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Rosalind Advisors, Inc. reported an equity portfolio of $292.6 Millions as of 30 Sep, 2025.
The top stock holdings of Rosalind Advisors, Inc. are DCTH, CYTK, FENC. The fund has invested 11.3% of it's portfolio in DELCATH SYS INC and 7.5% of portfolio in CYTOKINETICS INC.
The fund managers got completely rid off REPLIMUNE GROUP INC (REPL), UROGEN PHARMA LTD (URGN) and PHARVARIS N V (PHVS) stocks. They significantly reduced their stock positions in OCULAR THERAPEUTIX INC (OCUL), TREVI THERAPEUTICS INC (TRVI) and IDEAYA BIOSCIENCES INC (IDYA). Rosalind Advisors, Inc. opened new stock positions in EYEPOINT PHARMACEUTICALS INC (EYPT), FRACTYL HEALTH INC and ATYR PHARMA INC (LIFE). The fund showed a lot of confidence in some stocks as they added substantially to TALPHERA INC (ACRX), CYBIN INC (CYBN) and MEDIWOUND LTD.
The top stock holdings of Rosalind Advisors, Inc. are DCTH, CYTK, FENC. The fund has invested 11.3% of it's portfolio in DELCATH SYS INC and 7.5% of portfolio in CYTOKINETICS INC.
The fund managers got completely rid off REPLIMUNE GROUP INC (REPL), UROGEN PHARMA LTD (URGN) and PHARVARIS N V (PHVS) stocks. They significantly reduced their stock positions in OCULAR THERAPEUTIX INC (OCUL), TREVI THERAPEUTICS INC (TRVI) and IDEAYA BIOSCIENCES INC (IDYA). Rosalind Advisors, Inc. opened new stock positions in EYEPOINT PHARMACEUTICALS INC (EYPT), FRACTYL HEALTH INC and ATYR PHARMA INC (LIFE). The fund showed a lot of confidence in some stocks as they added substantially to TALPHERA INC (ACRX), CYBIN INC (CYBN) and MEDIWOUND LTD.
Rosalind Advisors, Inc. Annual Return Estimates Vs S&P 500
Our best estimate is that Rosalind Advisors, Inc. made a return of 23.11% in the last quarter. In trailing 12 months, it's portfolio return was 29.27%.
New Buys
| Ticker | $ Bought |
|---|---|
| eyepoint pharmaceuticals inc | 9,256,000 |
| fractyl health inc | 7,950,000 |
| atyr pharma inc | 7,564,500 |
| uniqure nv | 7,296,250 |
| x4 pharmaceuticals inc | 5,282,560 |
| astria therapeutics inc | 1,112,770 |
New stocks bought by Rosalind Advisors, Inc.
Additions
| Ticker | % Inc. |
|---|---|
| talphera inc | 118 |
| cybin inc | 84.98 |
| mediwound ltd | 84.02 |
| mind medicine mindmed inc | 78.57 |
| inspiremd inc | 70.62 |
| cg oncology inc | 55.46 |
| savara inc | 50.66 |
| biofrontera inc | 16.83 |
Additions to existing portfolio by Rosalind Advisors, Inc.
Reductions
| Ticker | % Reduced |
|---|---|
| ocular therapeutix inc | -67.18 |
| trevi therapeutics inc | -66.67 |
| ideaya biosciences inc | -31.52 |
| xeris biopharma holdings inc | -16.69 |
| viridian therapeutics inc | -14.29 |
| polypid ltd | -5.82 |
| verastem inc | -5.58 |
Rosalind Advisors, Inc. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| replimune group inc | -8,361,000 |
| urogen pharma ltd | -7,430,410 |
| ovid therapeutics inc | -164,950 |
| compass pathways plc | -1,351,420 |
| pharvaris n v | -3,935,840 |
| kalvista pharmaceuticals inc | -1,783,080 |
Rosalind Advisors, Inc. got rid off the above stocks
Sector Distribution
Rosalind Advisors, Inc. has about 82.7% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 82.7 |
| Others | 17.3 |
Market Cap. Distribution
Rosalind Advisors, Inc. has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MICRO-CAP | 39.9 |
| SMALL-CAP | 26.1 |
| UNALLOCATED | 17.3 |
| MID-CAP | 14.9 |
| NANO-CAP | 1.8 |
Stocks belong to which Index?
About 40.6% of the stocks held by Rosalind Advisors, Inc. either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 59.4 |
| RUSSELL 2000 | 40.6 |
Rosalind Advisors, Inc. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Rosalind Advisors, Inc.
Rosalind Advisors, Inc. has 29 stocks in it's portfolio. About 60.1% of the portfolio is in top 10 stocks. MYO proved to be the most loss making stock for the portfolio. VSTM was the most profitable stock for Rosalind Advisors, Inc. last quarter.
Last Reported on: 13 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACRX | talphera inc | 1.34 | 4,385,760 | 3,917,360 | added | 118 | ||
| ATXS | astria therapeutics inc | 0.38 | 1,542,520 | 1,112,770 | new | |||
| BFRI | biofrontera inc | 0.38 | 1,140,760 | 1,123,650 | added | 16.83 | ||
| CMPS | compass pathways plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CYBN | cybin inc | 3.02 | 1,500,000 | 8,835,000 | added | 84.98 | ||
| CYTK | cytokinetics inc | 7.51 | 400,000 | 21,984,000 | unchanged | 0.00 | ||
| DCTH | delcath sys inc | 11.28 | 3,300,390 | 33,003,900 | unchanged | 0.00 | ||
| EYPT | eyepoint pharmaceuticals inc | 3.16 | 650,000 | 9,256,000 | new | |||
| FENC | fennec pharmaceuticals inc | 6.64 | 2,076,840 | 19,439,200 | added | 1.52 | ||
| IDYA | ideaya biosciences inc | 3.26 | 350,000 | 9,523,500 | reduced | -31.52 | ||
| KALV | kalvista pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| KURA | kura oncology inc | 0.30 | 100,000 | 885,000 | unchanged | 0.00 | ||
| LIFE | atyr pharma inc | 2.59 | 1,039,080 | 7,564,500 | new | |||
| MNMD | mind medicine mindmed inc | 3.02 | 750,000 | 8,842,500 | added | 78.57 | ||
| MYO | myomo inc | 1.16 | 3,790,790 | 3,381,380 | added | 5.42 | ||
| NSPR | inspiremd inc | 3.22 | 3,905,740 | 9,412,840 | added | 70.62 | ||
| OCUL | ocular therapeutix inc | 1.60 | 400,000 | 4,676,000 | reduced | -67.18 | ||
| OVID | ovid therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| PHVS | pharvaris n v | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| QURE | uniqure nv | 2.49 | 125,000 | 7,296,250 | new | |||